Total Payments
$1,300
2024 Payments
$229.45
Companies
23
Transactions
72
Medicare Patients
4,237
Medicare Billing
$1.7M
Payment Breakdown by Category
Food & Beverage$1,300 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,300 | 72 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $293.48 | 20 | $0 (2024) |
| ABBVIE INC. | $152.64 | 5 | $0 (2024) |
| Amgen Inc. | $139.76 | 6 | $0 (2024) |
| LEO Pharma Inc. | $123.84 | 7 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $95.81 | 4 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $65.03 | 4 | $0 (2024) |
| Celgene Corporation | $48.03 | 3 | $0 (2018) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $48.00 | 3 | $0 (2022) |
| Incyte Corporation | $42.93 | 2 | $0 (2023) |
| Valeant Pharmaceuticals North America LLC | $40.59 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $229.45 | 11 | Regeneron Healthcare Solutions, Inc. ($83.69) |
| 2023 | $384.99 | 24 | Janssen Biotech, Inc. ($142.18) |
| 2022 | $127.34 | 8 | Janssen Biotech, Inc. ($73.32) |
| 2021 | $36.25 | 2 | Janssen Biotech, Inc. ($21.56) |
| 2019 | $20.31 | 1 | Ortho Dermatologics, a division of Bausch Health US, LLC ($20.31) |
| 2018 | $53.92 | 4 | LEO Pharma Inc. ($43.02) |
| 2017 | $447.52 | 22 | AbbVie, Inc. ($119.57) |
All Payment Transactions
72 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/13/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.80 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: Immunology | ||||||
| 10/15/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: Dermatology | ||||||
| 10/10/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.67 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/26/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $16.03 | General |
| Category: Immunology | ||||||
| 09/11/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: Inflammation | ||||||
| 07/24/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Immunology | ||||||
| 03/06/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $15.88 | General |
| Category: Immunology | ||||||
| 11/22/2023 | Organon LLC | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $10.33 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 11/07/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.31 | General |
| Category: Immunology | ||||||
| 11/07/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $3.45 | General |
| Category: Immunology | ||||||
| 10/20/2023 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: DERMATOLOGY | ||||||
| 10/10/2023 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: Immunology | ||||||
| 10/09/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Immunology | ||||||
| 08/24/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $33.30 | General |
| Category: Inflammation | ||||||
| 06/21/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $29.83 | General |
| Category: Inflammation | ||||||
| 05/10/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $24.09 | General |
| Category: Dermatology | ||||||
| 04/27/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: Immunology | ||||||
| 04/18/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.91 | General |
| Category: Immunology | ||||||
| 03/28/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $10.25 | General |
| Category: Immunology | ||||||
| 03/24/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $10.08 | General |
| Category: Immunology | ||||||
| 03/23/2023 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,016 | 1,093 | $650,877 | $391,951 |
| 2022 | 17 | 1,068 | 1,221 | $658,315 | $431,543 |
| 2021 | 12 | 1,127 | 1,250 | $702,663 | $463,533 |
| 2020 | 11 | 1,026 | 1,166 | $652,354 | $415,564 |
Total Patients
4,237
Total Services
4,730
Medicare Billing
$1.7M
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 421 | 466 | $359,720 | $228,913 | 63.6% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 113 | 135 | $66,311 | $45,250 | 68.2% |
| 15260 | Full thickness skin graft to nose, ears, eyelids, or lips, 20.0 sq cm or less | Office | 2023 | 47 | 47 | $60,920 | $37,588 | 61.7% |
| 14060 | Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | Office | 2023 | 29 | 29 | $26,780 | $18,167 | 67.8% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 119 | 124 | $41,104 | $16,093 | 39.2% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 24 | 25 | $18,529 | $12,260 | 66.2% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 34 | 35 | $17,500 | $6,798 | 38.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 66 | 68 | $6,404 | $4,588 | 71.6% |
| 13152 | Complicated repair of wound of eyelids, nose, ears, or lip, 2.6-7.5 cm | Office | 2023 | 22 | 22 | $11,264 | $4,495 | 39.9% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 24 | 24 | $10,851 | $4,215 | 38.8% |
| 12053 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 5.1-7.5 cm | Office | 2023 | 26 | 26 | $9,828 | $3,915 | 39.8% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 24 | 24 | $7,841 | $2,997 | 38.2% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 17 | 17 | $5,338 | $2,136 | 40.0% |
| 12051 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.5 cm or less | Office | 2023 | 15 | 15 | $4,425 | $1,762 | 39.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 23 | 23 | $2,671 | $1,678 | 62.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 12 | 13 | $1,391 | $1,095 | 78.7% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2022 | 407 | 499 | $347,300 | $239,092 | 68.8% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2022 | 137 | 180 | $76,140 | $60,046 | 78.9% |
| 15260 | Full thickness skin graft to nose, ears, eyelids, or lips, 20.0 sq cm or less | Office | 2022 | 40 | 40 | $40,560 | $32,277 | 79.6% |
| 14060 | Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | Office | 2022 | 30 | 30 | $23,340 | $18,593 | 79.7% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2022 | 32 | 35 | $22,750 | $17,429 | 76.6% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2022 | 85 | 88 | $44,356 | $17,340 | 39.1% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2022 | 97 | 102 | $33,493 | $13,280 | 39.6% |
| 13152 | Complicated repair of wound of eyelids, nose, ears, or lip, 2.6-7.5 cm | Office | 2022 | 33 | 33 | $16,896 | $6,734 | 39.9% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2022 | 34 | 37 | $16,620 | $6,693 | 40.3% |
About Dr. Kerri Robbins, MD
Dr. Kerri Robbins, MD is a MOHS-Micrographic Surgery healthcare provider based in Gig Harbor, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/22/2009. The National Provider Identifier (NPI) number assigned to this provider is 1831333749.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kerri Robbins, MD has received a total of $1,300 in payments from pharmaceutical and medical device companies, with $229.45 received in 2024. These payments were reported across 72 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($1,300).
As a Medicare-enrolled provider, Robbins has provided services to 4,237 Medicare beneficiaries, totaling 4,730 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty MOHS-Micrographic Surgery
- Location Gig Harbor, WA
- Active Since 04/22/2009
- Last Updated 04/30/2020
- Taxonomy Code 207ND0101X
- Entity Type Individual
- NPI Number 1831333749
Products in Payments
- TREMFYA (Drug) $269.73
- Humira (Biological) $119.57
- Otezla (Drug) $116.79
- DUPIXENT (Biological) $95.81
- ENSTILAR (Drug) $44.90
- ILUMYA (Biological) $43.35
- PICATO (Drug) $43.02
- OPZELURA (Drug) $42.93
- TALTZ (Drug) $39.40
- ADBRY (Biological) $35.92
- Enbrel (Biological) $33.87
- Sotyktu (Drug) $31.91
- SOLODYN (Drug) $25.83
- REMICADE (Biological) $23.75
- Cimzia (Drug) $22.91
- Finacea (Drug) $21.94
- Novacort (Drug) $21.71
- Winlevi (Drug) $21.68
- BRYHALI (Drug) $20.31
- BOTOX (Biological) $19.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.